Interferon. induced compositional changes in human bone marrow derived mesenchymal stem/stromal cells

被引:29
|
作者
Guan, Qingdong [1 ,2 ]
Ezzati, Peyman [3 ,4 ]
Spicer, Victor [3 ,4 ]
Krokhin, Oleg [3 ,4 ]
Wall, Donna [5 ]
Wilkins, John A. [3 ,4 ]
机构
[1] Univ Manitoba, Dept Pediat & Child Hlth, Manitoba Ctr Adv Cell & Tissue Therapy, Winnipeg, MB, Canada
[2] CancerCare Manitoba, Cellular Therapy Lab, Winnipeg, MB, Canada
[3] Univ Manitoba, Rady Fac Hlth Sci, Dept Internal Med, Manitoba Ctr Prote & Syst Biol,Sect Biomed Prote, 715 McDermot Ave, Winnipeg, MB R3E 3P4, Canada
[4] 799 John Buhler Res Ctr, Hlth Sci Ctr, 715 McDermot Ave, Winnipeg, MB R3E 3P4, Canada
[5] Univ Toronto, Hosp Sick Children, Dept Paediat, Div Haematol Oncol, Toronto, ON, Canada
关键词
Proteomics; Human; 2D LC mass spectrometry; Interferon gamma; Mesenchymal stem/stromal cells ( MSC); Quantitative proteome profiling; Licensing; Membrane; STROMAL CELLS; STEM-CELLS; IFN-GAMMA; INDOLEAMINE 2,3-DIOXYGENASE; PROSTACYCLIN SYNTHASE; TGF-BETA; INDUCTION; IMMUNOSUPPRESSION; SUPPRESSION; ACTIVATION;
D O I
10.1186/s12014-017-9161-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Mesenchymal stem/stromal cells ( MSC) display a range of immunoregulatory properties which can be enhanced by the exposure to cytokines such interferon. ( IFN-gamma).However the compositional changes associated with the 'licensing' of these cells have not been clearly defined. The present study was undertaken to provide a detailed comparative proteomic analysis of the compositional changes that occur in human bone marrow derived MSC following 20 h treatment with IFN-gamma. Methods: 2D LC MSMS analysis of control and IFN-gamma treated cells from 5 different healthy donors provided confident identification of more than 8400 proteins. Results: In total 210 proteins were shown to be significantly altered in their expression levels (>=|2SD|) following IFN-gamma treatment. The changes for several of these proteins were confirmed by flow cytometry. STRING analysis determined that approximately 30% of the altered proteins physically interacted in described interferon mediated processes. Comparison of the list of proteins that were identified as changed in the proteomic analysis with data for the same proteins in the Interferome DB indicated that similar to 35% of these proteins have not been reported to be IFN-gamma responsive in a range of cell types. Conclusions: This data provides an in depth analysis of the proteome of basal and IFN-gamma treated human mesenchymal stem cells and it identifies a number of novel proteins that may contribute to the immunoregulatory capacity if IFN-gamma licensed cells.
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Differential Immunomodulatory Effects of Human Bone Marrow-Derived Mesenchymal Stromal Cells on Natural Killer Cells
    Hu, Chia-Hsuan Donna
    Kosaka, Yoko
    Marcus, Paula
    Rashedi, Iran
    Keating, Armand
    STEM CELLS AND DEVELOPMENT, 2019, 28 (14) : 933 - 943
  • [22] Cellular Heterogeneity of Mesenchymal Stem/Stromal Cells in the Bone Marrow
    Mabuchi, Yo
    Okawara, Chikako
    Mendez-Ferrer, Simon
    Akazawa, Chihiro
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [23] Interferon-Gamma Impairs Maintenance and Alters Hematopoietic Support of Bone Marrow Mesenchymal Stromal Cells
    Goedhart, Marieke
    Cornelissen, Anne S.
    Kuijk, Carlijn
    Geerman, Sulima
    Kleijer, Marion
    van Buul, Jaap D.
    Huveneers, Stephan
    Raaijmakers, Marc H. G. P.
    Young, Howard A.
    Wolkers, Monika C.
    Voermans, Carlijn
    Nolte, Martijn A.
    STEM CELLS AND DEVELOPMENT, 2018, 27 (09) : 579 - 589
  • [24] BONE MARROW DERIVED MESENCHYMAL STEM CELLS AND AGING
    Gala, Kamila
    Burdzinska, Anna
    Paczek, Leszek
    POSTEPY BIOLOGII KOMORKI, 2010, 37 (01) : 89 - 106
  • [25] Global miRNA expression of bone marrow mesenchymal stem/stromal cells derived from Fanconi anemia patients
    Cagnan, Ilgin
    Keles, Mustafa
    Keskus, Ayse Gokce
    Tombaz, Melike
    Sahan, Ozge Burcu
    Aerts-Kaya, Fatima
    Uckan-Cetinkaya, Duygu
    Konu, Ozlen
    Gunel-Ozcan, Aysen
    HUMAN CELL, 2022, 35 (01) : 111 - 124
  • [26] Human mesenchymal progenitor cells derived from alveolar bone and human bone marrow stromal cells: a comparative study
    Pekovits, Karin
    Kroepfl, Julia Maria
    Stelzer, Ingeborg
    Payer, Michael
    Hutter, Heinz
    Dohr, Gottfried
    HISTOCHEMISTRY AND CELL BIOLOGY, 2013, 140 (06) : 611 - 621
  • [27] Phenotypic and Functional Characterizations of Mesenchymal Stem/Stromal Cells Isolated From Human Cranial Bone Marrow
    Yang, Kaichuang
    Lu, Ruijie
    Lu, Jianan
    Fan, Shucai
    Zhang, Qiang
    Lou, Zijian
    Ma, Yuyuan
    Lu, Gang
    Pan, Ruolang
    Zhang, Jianmin
    FRONTIERS IN NEUROSCIENCE, 2022, 16
  • [28] Transient Cell-to-Cell Signaling Before Mitosis in Cultures of Human Bone Marrow-Derived Mesenchymal Stem/Stromal Cells
    Cui, JianGuo
    Chen, Guanxing
    Perry, Anthony S.
    Abdi, Salahadin
    STEM CELLS AND DEVELOPMENT, 2019, 28 (02) : 120 - 128
  • [29] Targeting eradication of malignant cells derived from human bone marrow mesenchymal stromal cells
    Yang, Yingbin
    Cai, Shaoxi
    Yang, Li
    Yu, Shuhui
    Jiang, Jiahuan
    Yan, Xiaoqing
    Zhang, Haoxing
    Liu, Lan
    Liu, Qun
    Du, Jun
    Cai, Shaohui
    Sung, K. L. Paul
    EXPERIMENTAL CELL RESEARCH, 2010, 316 (20) : 3329 - 3341
  • [30] Immunomodulatory potential of cytokine-licensed human bone marrow-derived mesenchymal stromal cells correlates with potency marker expression profile
    Wang, Jiemin
    Zhou, Yingying
    Donohoe, Ellen
    Canning, Aoife
    Moosavizadeh, Seyedmohammad
    Ryan, Aideen E.
    Ritter, Thomas
    STEM CELLS, 2024, 42 (12) : 1040 - 1054